Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01665365
Other study ID # 30685
Secondary ID
Status Active, not recruiting
Phase N/A
First received August 13, 2012
Last updated April 13, 2015
Start date February 2007
Est. completion date December 2015

Study information

Verified date August 2013
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics CommitteeDenmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

The aim of this prospective follow-up study is to investigate 5-year clinical outcome in patients with ST-elevation myocardial infarction undergoing remote ischemic conditioning before primary percutaneous coronary intervention.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 251
Est. completion date December 2015
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Chest pain before admission to hospital within 12 h of onset, ST-segment elevation of > 0,1 mV in 2 or more contiguous leads, 18 years or older.

Exclusion Criteria:

- left bundle branch block, previous myocardial infarction, fibrinolytic treatment in the previous 30 days, previous coronary bypass surgery, left main stem stenosis requiring coronary bypass surgery, severe heart failure requiring mechanical ventilation or use of an intra-aortic balloon pump.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Remote ischemic perconditioning
Intermittent arm ischemia through four cycles of 5-min inflation and 5-min deflation of a blood-pressure cuff started in the ambulance before admission to primary percutaneous coronary intervention.

Locations

Country Name City State
Denmark Department of Cardiology, Aarhus University Hospital, Skejby Aarhus N

Sponsors (4)

Lead Sponsor Collaborator
University of Aarhus Aarhus University Hospital, Oxford University Hospitals NHS Trust, The Hospital for Sick Children

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Major adverse cardiac and cerebrovascular events (MACCE) MACCE defined as all-cause mortality, readmission for heart failure, myocardial infarction, and ischemic stroke/transient ischemic attack. Data are collected from Danish nationwide registries and medical records. 5 years No
Secondary LV-function and remodeling LV-function and remodeling measured by echocardiography. 5 years No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02601781 - Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry Phase 4
Completed NCT01747174 - REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction Phase 2
Completed NCT02788396 - The Impact of Post Stenting Balloon Dilatation on Coronary Microcirculation in STEMI Patients Undergoing PPCI
Recruiting NCT04825743 - A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI Phase 3